Cristina Ghenoiu

RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.

Capacity Bio is a therapeutics company that is focused on mitophagy.

Raised $35,000,000.00 from RA Capital Management and Insight Partners.

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Raised $153,000,000.00 from NVentures, Catalio Capital Management, Eli Lilly, Gaingels, RA Capital Management, Insight Partners and Cooley.

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

Raised $167,000,000.00 from RxCapital, BB Biotech Ventures, Medicxi, Bain Capital Life Sciences, RA Capital Management and Longitude Capital.

Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.

Raised $86,392,000.00 from ARCH Venture Partners, Longitude Capital, Adams Street Partners, Bluebird Ventures, Vertex Ventures HC and The Longevity Fund.

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

Raised $167,000,000.00 from RxCapital, BB Biotech Ventures, Medicxi, Bain Capital Life Sciences, RA Capital Management and Longitude Capital.

89Bio is a biopharmaceutical company building a pipeline of biologic and small molecule treatments for liver and metabolic disorders.

Raised $898,200,000.00 from K2 HealthVentures.